CLDX - CIK 0000744218
Celldex Therapeutics, Inc. has filed 1,268 documents with the SEC between 1995 and 2026. The most frequent type is insider trade (458 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2025-06-09 | 2025-06-05 |
| Insider trade | 4 | 2025-06-09 | 2025-06-05 |
| Insider trade | 4 | 2025-06-09 | 2025-06-05 |
| Insider trade | 4 | 2025-06-09 | 2025-06-05 |
| Insider trade | 4 | 2025-06-09 | 2025-06-05 |
| Insider trade | 4 | 2025-06-09 | 2025-06-05 |
| Employee stock plan | S-8 | 2025-06-06 | - |
| New insider ownership | 3 | 2025-06-06 | 2025-06-05 |
| Major company event | 8-K | 2025-06-06 | 2025-06-05 |
| SCHEDULE 13G/A | - | 2025-05-15 | - |
| SCHEDULE 13G/A | - | 2025-05-12 | - |
| Quarterly report | 10-Q | 2025-05-08 | 2025-03-31 |
| Major company event | 8-K | 2025-05-08 | 2025-05-08 |
| Annual report to shareholders | ARS | 2025-04-21 | 2024-12-31 |
| Proxy statement | DEF 14A | 2025-04-21 | 2025-06-05 |
| SCHEDULE 13G/A | - | 2025-04-17 | - |
| SCHEDULE 13G | - | 2025-04-10 | - |
| Annual report | 10-K | 2025-02-27 | 2024-12-31 |
| Major company event | 8-K | 2025-02-27 | 2025-02-27 |
| SCHEDULE 13G/A | - | 2025-02-14 | - |
| SCHEDULE 13G | - | 2025-02-14 | - |
| SCHEDULE 13G/A | - | 2025-02-12 | - |
| SCHEDULE 13G/A | - | 2025-02-05 | - |
| Insider trade | 4 | 2024-11-20 | 2024-11-18 |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-13 | - |
| Insider trade | 4 | 2024-11-12 | 2024-11-11 |
| Passive ownership stake (update) | SC 13G/A | 2024-11-12 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-08 | - |
| Quarterly report | 10-Q | 2024-11-06 | 2024-09-30 |
| Major company event | 8-K | 2024-11-06 | 2024-11-06 |
| Quarterly report | 10-Q | 2024-08-08 | 2024-06-30 |
| Major company event | 8-K | 2024-08-08 | 2024-08-08 |
| Insider trade | 4 | 2024-06-18 | 2024-06-14 |
| Insider trade | 4 | 2024-06-18 | 2024-06-14 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |